Madhumathi Palaniappan's Profile

B.Pharm

Madhumathi Palaniappan

Madhu, an alumni of Madras Medical College writes on drugs and handles the drug section on Medindia. Her long term dream and desire is to become an entrepreneur in the Pharma field.

Written / Edited / Medically Reviewed

FDA Approves Probuphine for Maintenance Treatment of Opioid Dependence

FDA Approves Probuphine for Maintenance Treatment of Opioid Dependence

The United States Food and Drug Administration Agency has approved Probuphine, the first buprenorphine implant to treat opioid dependence for a period of six months

Health In Focus
Essential Drugs Are Made Cheaper by 55% in India

Essential Drugs Are Made Cheaper by 55% in India

The National Pharmaceutical Pricing Authority of India reduces the prices of various drugs used in the treatment of cancer, diabetes and other critical diseases.

Health In Focus
Smart Drug ‘Synapsyl’ Fuels For a More Powerful Brain

Smart Drug ‘Synapsyl’ Fuels For a More Powerful Brain

Smart drug synapsyl is used as a cognitive enhancer by students, scientists and entrepreneurs for improving memory power and to elevate the energy levels.

Health In Focus
Drug Overdose

Drug Overdose

Drug overdose involves the intake of drug in excessive quantity than the recommended dose. It is due to overuse of over-the-counter medications or illegal drugs.

Disease & Condition
'Miracle Drug' Bedaquiline on Trial for Multidrug Resistance Tuberculosis (MDR-TB)

'Miracle Drug' Bedaquiline on Trial for Multidrug Resistance Tuberculosis (MDR-TB)

Multidrug resistant tuberculosis occurs due to the bacterial resistance for the first line anti-TB drugs. Bedaquiline a miracle drug has the potential to save many lives and eradicate the infection.

Health In Focus